Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Excelsior Medical CoTPE:4104 -1.13%87 ROC (Joel Greenblatt) % is 117.72% as of Mar. 2026, which is 5% above its 10-year median of 111.94. GuruFocus rates TPE:4104 with a GF Score™ of 87/100 and a GF Value™ of NT$87.68 (Modestly Undervalued). The stock has 5 warning signs investors should review. Among 119 Medical Distribution companies, Excelsior Medical Co ranks better than 94.12% on this metric.
Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits). He defines ROC (Joel Greenblatt) % as EBIT divided by the total of Property, Plant and Equipment and net working capital. Excelsior Medical Co's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was 117.72%.
The historical rank and industry rank for Excelsior Medical Co's ROC (Joel Greenblatt) % or its related term are showing as below:
TPE:4104'
s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: 100.33 Med: 111.94 Max: 240.84
Current: 116.07
During the past 13 years, Excelsior Medical Co's highest ROC (Joel Greenblatt) % was 240.84%. The lowest was 100.33%. And the median was 111.94%.
TPE:4104's ROC (Joel Greenblatt) % is ranked better than 94.12% of 119
companies
in the Medical Distribution industry
Industry Median: 15.14
vs TPE:4104: 116.07
Excelsior Medical Co's 5-Year average Growth Rate of ROC (Joel Greenblatt) % was 2.40% per year.
Excelsior Medical Co (TPE:4104) ROC (Joel Greenblatt) % Explanation
The way Joel Greenblatt defines Return on Capital is a more accurate measure of how efficiently the company generates returns onthe capital actually invested in the business. EBIT is used instead of net income because the tax and interest payment may be affected by factors other than the core business operation. Intangible assets are not included in the calculation because they don't need to be replaced.
Excelsior Medical Co ROC (Joel Greenblatt) % Related Terms
Excelsior Medical Co ROC (Joel Greenblatt) % Historical Data
* Premium members only.
The historical data trend for Excelsior Medical Co's ROC (Joel Greenblatt) % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Excelsior Medical Co ROC (Joel Greenblatt) % Chart
TPE:4104 vs MCK, COR, CAH: ROC (Joel Greenblatt) % Comparison
For the Medical Distribution subindustry, Excelsior Medical Co's ROC (Joel Greenblatt) %, along with its competitors' market caps and ROC (Joel Greenblatt) % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Excelsior Medical Co ROC (Joel Greenblatt) % vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Excelsior Medical Co's ROC (Joel Greenblatt) % distribution charts can be found below:
* The bar in red indicates where Excelsior Medical Co's ROC (Joel Greenblatt) % falls into.
Excelsior Medical Co ROC (Joel Greenblatt) % Calculation
Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits) . He defines Return on Capital as follows:
EBIT stands for Earnings Before Interest and Taxes.
Fixed Assets are also known as non-current assets. They include the Property, Plant and Equipment that the firm needs in its operation.
GuruFocus calculates net working capital as: (Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Deferred Revenue + Other Current Liabilities). We're trying to account for OPERATING assets and liabilities (part of daily business) when calculating working capital. Cash and marketable securities are considered NON-OPERATING assets and are not included in calculation. We will also back out all interest bearing debt, short term debt and the portion of long term debt that is due in the current period from the current liabilities. This debt will be considered when computing cost of capital and it would be inappropriate to count it twice.
Note:
The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a ROC (Joel Greenblatt) % of 117.72% mean?
Excelsior Medical Co (TPE:4104) has a ROC (Joel Greenblatt) % of 117.72% as of Mar. 2026. Joel Greenblatt's return on capital is the ratio of EBIT to average fixed assets and net working capital. View historical data on Excelsior Medical Co and its competitors. This is near median its historical median of 111.94. Over the past decade, Excelsior Medical Co's ROC (Joel Greenblatt) % has ranged from 100.33 to 240.84. According to the industry distribution chart, Excelsior Medical Co ranks #7 out of 119 companies in the Medical Distribution industry, placing it in the top 5.9%.
Is Excelsior Medical Co's ROC (Joel Greenblatt) % too high?
Excelsior Medical Co's current ROC (Joel Greenblatt) % of 117.72% is near median its 10-year median of 111.94. Over the past 10 years, this metric has ranged from a low of 100.33 to a high of 240.84. The Medical Distribution industry median ROC (Joel Greenblatt) % is 15.14. Excelsior Medical Co's value of 117.72% is 677.5% above this industry median. Based on the distribution chart, Excelsior Medical Co ranks #7 out of 119 companies in the Medical Distribution industry, which is in the top quartile — a strong position relative to peers. Overall, Excelsior Medical Co has a GF Score™ of 87/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Excelsior Medical Co's ROC (Joel Greenblatt) % compare to MCK and COR?
According to the Medical Distribution industry distribution chart, Excelsior Medical Co ranks #7 out of 119 companies for ROC (Joel Greenblatt) %. This places Excelsior Medical Co in the top 6% of its industry — outperforming the majority of peers. The industry median ROC (Joel Greenblatt) % is 15.14. Excelsior Medical Co's value of 117.72% is 677.5% above this benchmark. Historically, Excelsior Medical Co's own ROC (Joel Greenblatt) % has ranged from 100.33 to 240.84 over the past decade. While the company's 10-year median is 111.94 vs. the industry median of 15.14, Excelsior Medical Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROC (Joel Greenblatt) % for a Medical Distribution company?
The median ROC (Joel Greenblatt) % among Medical Distribution companies is 15.14, based on 119 companies in the industry. Companies in the top quartile (top 25%) have a ROC (Joel Greenblatt) % significantly above this median, while those in the bottom quartile fall well below. However, ROC (Joel Greenblatt) % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Excelsior Medical Co's current ROC (Joel Greenblatt) % of 117.72% is 677.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROC (Joel Greenblatt) % mean?
A high ROC (Joel Greenblatt) % can signal that a stock is expensive relative to its fundamentals. Joel Greenblatt's return on capital is the ratio of EBIT to average fixed assets and net working capital. View historical data on Excelsior Medical Co and its competitors. For the Medical Distribution industry, the median ROC (Joel Greenblatt) % is 15.14 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Excelsior Medical Co's current ROC (Joel Greenblatt) % is 117.72%, which is near median its own 10-year median of 111.94. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Excelsior Medical Co stock overvalued right now?
Based on GuruFocus' analysis, Excelsior Medical Co (TPE:4104) is currently considered Modestly Undervalued. The stock's GF Value™ is NT$87.68, compared to a current price of NT$70.00 — trading 20.2% below its estimated fair value. The current ROC (Joel Greenblatt) % is 117.72%, which is near median its 10-year median of 111.94 and 677.5% above the Medical Distribution industry median of 15.14. Excelsior Medical Co's overall GF Score™ is 87/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROC (Joel Greenblatt) % calculated?
ROC (Joel Greenblatt) % is calculated from a company's financial statements. For Excelsior Medical Co (TPE:4104), the current ROC (Joel Greenblatt) % is 117.72% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Excelsior Medical Co (TPE:4104) Overvalued in 2026?
Based on GuruFocus' analysis, Excelsior Medical Co stock appears to be undervalued.
The current stock price of NT$70.00 is trading 20.2% below its estimated GF Value™ of NT$87.68.
GuruFocus considers Excelsior Medical Co to be Modestly Undervalued.
Key valuation signals for TPE:4104:
ROC (Joel Greenblatt) %: 117.72% (near median its 10-year median of 111.94)
GF Value™: NT$87.68 vs. price of NT$70.00 (20.2% below fair value)
Industry Position: 677.5% above the Medical Distribution median (#7 of 119)
No single metric tells the full story. See the TPE:4104 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Excelsior Medical Co Ltd is engaged in the sale of medical supplies and medicines, home medical devices, and medical equipment with brand names of local and foreign manufacturers. Its product offerings include Fasflo hollow fiber dialyzer, Renabio sodium chloride injection, acid concentrates, Sunder blood purification tubing set, JMS blood bags, etc. The Group's reportable segments include Excelsior, Dynamic, Arich, and Others. Maximum revenue is generated from the Excelsior segment. Geographically, it derives key revenue from Taiwan and also has a presence in Hong Kong, China, the Philippines, Malaysia, and Indonesia.
87GF Score
Get the complete analysis for TPE:4104
ROC (Joel Greenblatt) % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TPE:4104 has been successfully added to your 
